Pancreatic cancer mRNA vaccine shows lasting results in an early trial

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

This post was originally published on NBC News.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *